Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine

Journal of Korean Medical Science

Volumn 16, Issue 5, 2001, Pages 636-642

  Lee, Jung Il ^a   Shin, Hee Jung ^a   Nan, Do Hyun ^a   Kim, Jong Soo ^a   Hong, Seung Chyul ^a   Shin, Hyung Jin ^a   Park, Kwan ^a   Eoh, Whan ^a   Kim, Jong Hyun ^a   Lee, Won Yong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Dyskinesias; Parkinsonian Disorders; Quinpirole; Substantia Nigra

Indexed keywords

APOMORPHINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; OXIDOPAMINE; QUINPIROLE;

ANIMAL; ARTICLE; DRUG EFFECT; INTOXICATION; MALE; PARKINSONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA;

ANIMALS; APOMORPHINE; DOPAMINE AGONISTS; MALE; MPTP POISONING; OXIDOPAMINE; PARKINSONIAN DISORDERS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA;

EID: 0035490577     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.5.636     Document Type: Article

References (32)

1. Marsden CD, Parkes JD. Success and problems of long-term levodopa therapy in Parkinsons disease. Lancet 1977; 1: 345-9.
2. Obeso JA, Grandas F, Vaamonde J, Luquin MR, Artieda J, Lera G, Rodriguez ME, Martinez-Lage JM. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology 1989; 39: 11-9.
3. 3H]Spiperone binding. Brain Res 1986; 379: 294-9.
4. Calne DB, Teychenne PF, Claveria LE, Eastman R, Greenacre JK, Petrie A. Bromocriptine in parkinsonism. Br Med J 1974; 4: 441-4.
5. Lees AJ, Stern GM. Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease. J Neurol Neurosurg Psychiat 1981; 44: 1020-3.
6. Bedard PJ, Mancilla BG, Blanchett P, Gagnon C, Di Paolo T. Levodopa-induced dyskinesia: facts and fancy. What does the MPTP monkey model tell us? Can J Neurol Sci 1992; 19: 134-7.
7. Blanchet PJ, Gomez-Mancilla B, Bedard PJ. DOPA-induced 'peak-dose' dyskinesia: clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys. J Neural Transm 1995; 45: 103-12.
8. Pearce RK, Banerji T, Jenner P, Marsden CD. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset. Mov Disord 1998; 13: 234-41.
9. Bevan P. Repeated apomorphine treatment causes behavioural super-sensitivity and dopamine D2 receptor hyposensitivity. Neurosci Lett 1983; 35: 185-9.
10. Carey RJ. Naloxone reverses L-DOPA induced overstimulation effects in a Parkinson's disease animal model analogue. Life Sci 1991; 48: 1303-8.
11. Duty S, Brotchie JM. Enhancement of behavioural response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression. Exp Neurol 1997; 144: 423-32.
12. Henry B, Crossman AR, Brotchie JM. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Exp Neurol 1998; 151: 334-42.
13. Murer MG, Riquelme LA, Tseng KY, Pazo JH. Substantiel nigra pars reticulata single unit activity in normal and 6-OHDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse 1997; 27: 278-93.
14. Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970; 24: 485-93.
15. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 1971; 367: 69-93.
16. Hong KS, Kim BG, Jeon BS, Yoon BW, Lee KW, Roh JK, Lee SB, Myung HJ. Chronological changes in the rotational behavior in response to apomorphine administration in 6-hydroxydopamine parkinsonian rat. J Korean Neurol Ass 1999; 17: 117-21.
17. Legendy CR, Salcman M. Bursts and recurrences of bursts in the spike trains of spontaneous active striate cortex neurons. J Neurophysiol 1985; 53: 926-39.
18. Burbaud P, Gross C, Benazzouz A, Coussemacq M, Bioulac B. Reduction of apomorphine-induced rotational behavior by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalisation of firing rate and discharge pattern of pars reticulata neurons. Exp Brain Res 1995; 105: 48-58.
19. Rohlfs A, Nikkhah G, Rosenthal C, Rundfeldt C, Brandis A, Samii M, Loscher W. Hemispheric asymmetries in spontaneous firing characteristics of substantia nigra pars reticulata neurons following a unilateral 6-hydroxydopamine lesion of the rat nigrostriatal pathway. Brain Res 1997; 761: 352-6.
20. Robledo P, Féger J. Acute monoaminergic depletion in the rat potentiates the excitatory effect of the subthalamic nucleus in the substantia nigra pars reticulata but not in the pallidal complex. J Neural Transm 1991; 86: 115-26.
21. Filion M. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey. Brain Res 1979; 178: 425-41.
22. Miller WC, DeLong MR. Parkinsonian symptomatology: an anatomical and physiological analysis. Ann NY Acad Sci 1988; 515: 287-302.
23. Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991; 547: 142-51.
24. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994; 72: 507-20.
25. Wichmann T, Bergman H, Starr PA, Subrmanian T, Watts RL, DeLong MR. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticutata in primates. Exp Brain Res 1999; 125: 397-409.
26. Hutchison WD, Lozano AM, Tasker RR, Lang AE, Dostorovsky JO. Identification and characterization of neurons with tremor-frequency activity in human globus pallidus. Exp Brain Res 1997; 113: 557-63.
27. Weick BG, Walters JR. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats: D1/D2 coactivation induces potentiated responses. Brain Res 1987; 405: 234-46.
28. Tseng KY, Riquelme LA, Belforte JE, Pazo JH, Murer MG. Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions. Eur J Neurosci 2000; 12: 247-56.
29. Ganteras NS, Shammah-Lagnado SJ, Silva BA, Ricardo JA. Somatosensory inputs to the subthalamic nucleus: A combined retrograde and antegrade HRP study in the rat. Brain Res 1988; 458: 53-64.
30. Mouroux M, Feger J. Evidence that the parafascicular projection to the subthalamic nucleus is glutamatergic. Neuro Report 1993; 4: 613-5.
31. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsna FJ, Jr., Sibley DR. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990; 250: 1429-32.
32. Pollack AE, Turgeon SM, Fink JS. Apomorphine priming alters the responses of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats. Neuroscience 1997; 79: 79-93.